Total submissions: 6
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Gene |
RCV001531173 | SCV000057427 | benign | not provided | 2015-03-03 | criteria provided, single submitter | clinical testing | |
Invitae | RCV000033522 | SCV000287697 | likely benign | RASopathy | 2023-11-27 | criteria provided, single submitter | clinical testing | |
Women's Health and Genetics/Laboratory Corporation of America, |
RCV001264432 | SCV001442573 | likely benign | not specified | 2020-10-24 | criteria provided, single submitter | clinical testing | |
Ce |
RCV001531173 | SCV001746166 | likely benign | not provided | 2021-04-01 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV002381282 | SCV002694411 | likely benign | Cardiovascular phenotype | 2018-11-26 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
KCCC/NGS Laboratory, |
RCV003315539 | SCV004017216 | benign | Juvenile myelomonocytic leukemia | 2023-07-07 | criteria provided, single submitter | clinical testing |